IntrinsicIntrinsic
← Scroll for more →

Financial Statements — CV

Balance Sheet

(in millions USD)
MetricQ2 2026Q1 2026Q3 2025Q2 2025
Accounts Receivable2.271.931.871.85
Inventory4.703.493.193.04
Total Current Assets17.2824.5024.057.80
Property, Plant & Equipment0.560.620.640.68
Total Non-current Assets*1.291.451.621.75
Total Assets18.5725.9525.669.55
Accounts Payable0.481.361.351.16
Total Current Liabilities5.165.364.644.22
Total Non-current Liabilities*0.250.360.580.69
Total Liabilities5.405.735.224.91
Retained Earnings(170.18)(162.70)(148.27)(140.35)
Total Stockholder Equity13.1720.2220.44(138.99)
← Scroll for more columns →

* Derived from reported values

Income Statement

(in millions USD) (except per-share rows)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Total Revenue3.642.793.923.543.32
Cost of Revenue1.771.461.961.621.50
Gross Profit1.871.331.951.911.81
Research & Development5.314.435.726.093.39
Selling, General & Admin2.211.901.752.071.22
Total Operating Expenses9.458.429.429.936.46
Operating Income(7.58)(7.09)(7.46)(8.02)(4.65)
Pretax Income(7.48)(7.03)(7.37)(7.92)(4.62)
Tax Provision0.000.000.020.000.00
Net Income(7.48)(7.03)(7.39)(7.92)(4.62)
Basic EPS(0.15)(0.15)0.02(0.17)(2.02)
Diluted EPS(0.15)(0.15)0.02(0.17)(2.02)
← Scroll for more columns →

Cash Flow Statement

(in millions USD)
MetricQ2 2026Q1 2026Q4 2025Q3 2025Q2 2025
Operating Cash Flow(8.40)(6.07)(7.69)(5.67)(9.51)
Capital Expenditures0.000.050.010.010.07
Free Cash Flow*(8.40)(6.11)(7.69)(5.68)(9.58)
Investing Cash Flow0.00(0.05)(0.01)(0.01)(0.07)
Financing Cash Flow(0.44)13.950.0222.391.20
← Scroll for more columns →

* Derived from reported values